BioCentury
ARTICLE | Company News

Ziconotide NDA accepted for filing

February 29, 2000 8:00 AM UTC

Elan (ELN) said the FDA accepted for filing its NDA for Ziconotide N-type neuronal calcium channel blocker to treat severe chronic pain via the intrathecal route. The compound is under a six-month rev...